Diabetes: The role o intracvitreous anti-VEGF-learnings from the DRCR.net
Category: Training - Other
Date: September 25th 2015 1:00pm until 5:30pm
Location: Marriott Royal Hotel, Bristol BS1 3AD
A scientific meet-the-expert session, exploring the latest updates from the DRCR.net provided by Bayer HealthCare Pharmaceuticals UK.
This scientific meeting has been designed by an expert faculty including Mr Richard Gale (York Teaching Hospital NHS Foundation Trust) and Dr Neil M Bressler and Dr Susan Bressler (Johns Hopkins University School of Medicine, Baltimore, MD USA (participation by Drs Bresslers does not constitute or imply endorsement by the John Hopkins University or John Hopkins Health System).
Programme:
| Time | Topic | Presenter |
| 13.00 | Buffett Lunch | |
| 14.00 | Welcome and Introductions | Mr Adam Ross |
| 14.05 | Quantitative analysis of the outcome of VEGF treatment for Nneovascular macular degeneration | Mr Richard Gale |
| 14.30 | Q&A | All |
| 14.45 | Discussion: The role of the DRCR.net, new data and relevance for the UK | Dr Neil Bressler |
| 15.30 | Q&A | All |
| 15.45 | Coffee break | |
| 16.00 |
Understanding 2 year results from the DRCR.net Protocol S: PRP vs anti-VEGF for proliferative diabetic retinopathy |
Dr Susan Bressler |
| 16.45 | Q&A | All |
| 17.00 | Case study review and audience Q&A | All |
| 17.30 | Summary and close | Mr Adam Ross |
Please register to attend via email BristolBayerRetinaUpdate@porterhouse.biz
Following registration parking and venue details will be sent.
Please phone 0118 913 9100 for further information